Literature DB >> 32725167

Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Sara M O'Rourke1, Giora I Morozov1, Jacob T Roberts2, Adam W Barb2,3, Nikolaos G Sgourakis1.   

Abstract

Current approaches for generating major histocompatibility complex (MHC) Class-I proteins with desired bound peptides (pMHC-I) for research, diagnostic and therapeutic applications are limited by the inherent instability of empty MHC-I molecules. Using the properties of the chaperone TAP-binding protein related (TAPBPR), we have developed a robust method to produce soluble, peptide-receptive MHC-I molecules in Chinese Hamster Ovary cells at high yield, completely bypassing the requirement for laborious refolding from inclusion bodies expressed in E.coli. Purified MHC-I/TAPBPR complexes can be prepared for multiple human allotypes, and exhibit complex glycan modifications at the conserved Asn 86 residue. As a proof of concept, we demonstrate both HLA allele-specific peptide binding and MHC-restricted antigen recognition by T cells for two relevant tumor-associated antigens. Our system provides a facile, high-throughput approach for generating pMHC-I antigens to probe and expand TCR specificities present in polyclonal T cell repertoires.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HLA; MHC tetramer; TAPBPR; TCR repertoire; molecular diagnostics

Mesh:

Substances:

Year:  2019        PMID: 32725167      PMCID: PMC7451022          DOI: 10.1093/protein/gzaa015

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  50 in total

Review 1.  Secrets of a covalent interaction for biomaterials and biotechnology: SpyTag and SpyCatcher.

Authors:  Samuel C Reddington; Mark Howarth
Journal:  Curr Opin Chem Biol       Date:  2015-10-30       Impact factor: 8.822

2.  Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.

Authors:  F Tudor Ilca; Andreas Neerincx; Mark R Wills; Maike de la Roche; Louise H Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

3.  Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.

Authors:  Giora I Morozov; Huaying Zhao; Michael G Mage; Lisa F Boyd; Jiansheng Jiang; Michael A Dolan; Ramesh Venna; Michael A Norcross; Curtis P McMurtrey; William Hildebrand; Peter Schuck; Kannan Natarajan; David H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

4.  NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.

Authors:  Vanessa Jurtz; Sinu Paul; Massimo Andreatta; Paolo Marcatili; Bjoern Peters; Morten Nielsen
Journal:  J Immunol       Date:  2017-10-04       Impact factor: 5.422

Review 5.  NY-ESO-1: review of an immunogenic tumor antigen.

Authors:  Sacha Gnjatic; Hiroyoshi Nishikawa; Achim A Jungbluth; Ali O Güre; Gerd Ritter; Elke Jäger; Alexander Knuth; Yao-Tseng Chen; Lloyd J Old
Journal:  Adv Cancer Res       Date:  2006       Impact factor: 6.242

6.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

7.  Structure of the TAPBPR-MHC I complex defines the mechanism of peptide loading and editing.

Authors:  Christoph Thomas; Robert Tampé
Journal:  Science       Date:  2017-10-12       Impact factor: 47.728

Review 8.  MHC Molecules, T cell Receptors, Natural Killer Cell Receptors, and Viral Immunoevasins-Key Elements of Adaptive and Innate Immunity.

Authors:  Jiansheng Jiang; Kannan Natarajan; David H Margulies
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  CHO-S antibody titers >1 gram/liter using flow electroporation-mediated transient gene expression followed by rapid migration to high-yield stable cell lines.

Authors:  Krista Steger; James Brady; Weili Wang; Meg Duskin; Karen Donato; Madhusudan Peshwa
Journal:  J Biomol Screen       Date:  2014-12-17

10.  CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.

Authors:  Gabriel Byrne; Sara M O'Rourke; David L Alexander; Bin Yu; Rachel C Doran; Meredith Wright; Qiushi Chen; Parastoo Azadi; Phillip W Berman
Journal:  PLoS Biol       Date:  2018-08-29       Impact factor: 8.029

View more
  5 in total

Review 1.  Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells.

Authors:  Zheng-Mei Li; Zhen-Lin Fan; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-04

2.  TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.

Authors:  Andrew C McShan; Christine A Devlin; Giora I Morozov; Sarah A Overall; Danai Moschidi; Neha Akella; Erik Procko; Nikolaos G Sgourakis
Journal:  Nat Commun       Date:  2021-05-26       Impact factor: 14.919

Review 3.  Dynamics of MHC-I molecules in the antigen processing and presentation pathway.

Authors:  Hau V Truong; Nikolaos G Sgourakis
Journal:  Curr Opin Immunol       Date:  2021-06-18       Impact factor: 7.268

Review 4.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

Review 5.  Chaperones and Catalysts: How Antigen Presentation Pathways Cope With Biological Necessity.

Authors:  David H Margulies; Daniel K Taylor; Jiansheng Jiang; Lisa F Boyd; Javeed Ahmad; Michael G Mage; Kannan Natarajan
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.